Enveric Biosciences (NASDAQ:ENVB) and STMicroelectronics (NYSE:STM) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.
Volatility and Risk
Enveric Biosciences has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, STMicroelectronics has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500.
This table compares Enveric Biosciences and STMicroelectronics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Valuation and Earnings
This table compares Enveric Biosciences and STMicroelectronics’ revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Enveric Biosciences||$39.92 million||1.30||-$6.86 million||N/A||N/A|
|STMicroelectronics||$10.22 billion||3.37||$1.11 billion||$1.21||31.26|
STMicroelectronics has higher revenue and earnings than Enveric Biosciences.
Institutional and Insider Ownership
4.4% of Enveric Biosciences shares are held by institutional investors. Comparatively, 4.5% of STMicroelectronics shares are held by institutional investors. 1.0% of Enveric Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This is a breakdown of current recommendations and price targets for Enveric Biosciences and STMicroelectronics, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
STMicroelectronics has a consensus target price of $49.33, indicating a potential upside of 30.44%. Given STMicroelectronics’ higher probable upside, analysts clearly believe STMicroelectronics is more favorable than Enveric Biosciences.
STMicroelectronics beats Enveric Biosciences on 9 of the 11 factors compared between the two stocks.
Enveric Biosciences Company Profile
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. It has a pipeline of development programs for radiodermatitis, glioblastoma multiforme, pruritus, rashes, and dry skin and chemotherapy-induced neuropathy. The company is headquartered in Naples, Florida.
STMicroelectronics Company Profile
STMicroelectronics N.V., together with its subsidiaries, designs, develops, manufactures, and markets semiconductor products in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates through Automotive and Discrete Group; Analog, MEMS and Sensors Group; and Microcontrollers and Digital ICs Group segments. The Automotive and Discrete Group segment offers automotive integrated circuits (ICs); and discrete and power transistor products. The Analog, MEMS and Sensors Group segment provides industrial application-specific integrated circuits (ASICs) and application-specific standard products (ASSPs); general purpose analog products; custom analog ICs; wireless charging solutions; galvanic isolated gate drivers; low and high voltage amplifiers, comparators, and current-sense amplifiers; MasterGaN, a solution that integrates a silicon driver and GaN power transistors in a single package; wireline and wireless connectivity ICs; touch screen controllers; micro-electro-mechanical systems (MEMS) products, including sensors or actuators; and optical sensing solutions. The Microcontrollers and Digital ICs Group segment offers general purpose and secure microcontrollers; radio frequency (RF) and electrically erasable programmable read-only memories; and RF, digital, and mixed-signal ASICs. It also provides assembly and other services. The company sells its products through distributors and retailers, as well as through sales representatives. STMicroelectronics N.V. was incorporated in 1987 and is headquartered in Geneva, Switzerland.
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.